Objective: There is still much to be discovered regarding the etiopathogenesis and management of polycystic ovarian syndrome (PCOS). Materials and Methods: Four groups of female Wister-Albino rats were established, each with a normal estrous cycle: control, D ( + ) galactose (D-galactose), Lepidium sativum (L. sativum), and prepared secondary antibody (Ab2). Serum samples were collected, and histopathological examination was performed on ovaries and spleen tissues. Immunoreactive anti-ovarian antibody (AOA) quantities were determined using a modified antigen-based ELISA procedure. ELISA assay kits were used to quantify FSH, LH, and estradiol 17 β concentrations. Results: The study found that AOA concentration in undiluted samples was significantly higher in the second and fourth weeks after PCOS induction by D-galactose (p < 0.001). However, antibody index% and titer elevated in the D-galactose group. L. sativum's late efficacy was observed in the fourth week, while the concentration of undiluted samples in the D-galactose + Ab2 group lowered (p < 0.001). Higher basal FSH and LH levels and lower estrogen levels are associated with PCOS development. L. sativum's immunomodulatory properties may contribute to this associa¬tion. Estradiol-17ß concentrations increased in D-galactose + L. sativum and D-galactose + Ab2 groups, respectively. Conclusion: Careful extrapolation of experimental models is crucial for clinical applications, as technical advancements make Ab2 production easier. Further study is needed to fully understand its potential in immunotherapy. [J Adv Vet Anim Res 2024; 11(2.000): 418-428]

The objective of current study was to evaluate the effects of Lepidium sativum (LS) on liver histopathology and serum biochemistry in rats fed with high cholesterol diet. A total of 32 rats were divided into four equal groups. The rats of first group (control group) were fed with basal diet, whereas the rats of second group were fed with basal diet mixed with cholesterol (1%). The rats of third and fourth groups were fed with high cholesterol (1%) diet mixed with Lepidium sativum powder at 3 g and 6 g/kg diet, respectively. Total cholesterol, triacylglycerol and alanine transaminase (ALT) activity were increased significantly in the rats fed with high cholesterol diet as compared to control group. LS reduced total cholesterol and ALT; however, higher dose (6 g/kg diet) was found better than lower dose (3 g/kg diet) in reducing serum triacylglycerol. Histopathological findings revealed that liver of cholesterol-treated rats showed varying degrees of vacuolar degeneration, fatty changes, fatty cysts, and lobular disarray. Livers of the LS-treated rats revealed mild to moderate degree of recovery. Conclusively, high dose of LS is recommended as hypocholesterolemic and hypolipidemic agent in rats.